查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553442

纽约合法大麻市场规模、份额和趋势分析：按来源、衍生物、种植、最终用途和细分市场预测（2024-2030）

New York Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By Cultivation (Indoor Cultivation, Greenhouse Cultivation), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

纽约合法大麻市场成长与趋势

Grand View Research, Inc.最新报告显示，预计2030年纽约合法大麻市场规模将达32.2亿美元，2024年至2030年复合年增长率为15.3%。药用大麻合法化、消费者可支配收入增加、消费者对大麻健康益处的认识提高、製药业对大麻的需求增加以及美国农业法案的核准等因素预计将推动市场成长。

成年人使用大麻来治疗各种疾病，包括心理健康问题、癌症、噁心和疼痛。在预测期内，癌症盛行率的不断上升预计将极大促进医用大麻的接受度不断提高。例如，根据纽约政府公布的资料，每年有116,000名纽约人被诊断出罹患癌症。

大众对大麻治疗角色的认识不断提高，大麻认证教育和培训计画数量不断增加，正在推动市场成长。例如，旅行培训计划是纽约州大麻劳动力计划的一部分。这是康乃尔大学工业与劳动关係学院和非营利劳动发展研究所之间的合作项目，部分资金来自国家。该计划已成功对数百人进行了大麻产业基本方面的教育。

此外，与大麻相关的研究活动的增加正在推动市场成长。 2023年8月，大麻研究许可证法规实施。该法规允许获得许可的研究人员测试大麻的成分水平和化学效力，研究大麻作为医疗的安全性和有效性，进行农业和基因组研究，并对可种植、加工的大麻衍生药物进行临床研究。和拥有用于执行等目的。

纽约合法大麻市场报告亮点

  • 从来源来看，由于对医用大麻的研究和研究不断增加，大麻细分市场在 2023 年占据了最大的收益占有率。
  • 从衍生性商品来看，由于注入 CBD 的药品、食品和化妆品越来越多地被采用，CBD 细分市场在 2023 年占据了最大的收益占有率。
  • 从种植来看，由于有利的政府法规和大麻种植者数量的增加，2023年室内种植领域占据了最大的收益占有率。
  • 以最终用途划分，由于越来越多的消费者以吸烟和电子烟的形式消费大麻，娱乐用途细分市场在 2023 年占据了最大的市场占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章纽约合法大麻市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 案例研究分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
  • 监管状况

第四章纽约合法大麻市场細項分析：依来源分类（2018-2030）

  • 定义和范围
  • 源细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • 麻
    • 市场估计与预测（2018-2030）
    • 油
    • 工业大麻
  • 大麻
    • 市场估计与预测（2018-2030）
    • 花
    • 油和酊剂

第五章纽约合法大麻市场細項分析：依衍生性商品分类（2018-2030）

  • 定义和范围
  • 衍生性细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • CBD
    • 市场估计与预测（2018-2030）
  • THC
    • 市场估计与预测（2018-2030）
  • 其他的
    • 市场估计与预测（2018-2030）

第六章 纽约合法大麻市场細項分析：依种植情况分类（2018-2030）

  • 定义和范围
  • 种植细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • 室内栽培
    • 市场估计与预测（2018-2030）
  • 温室栽培
    • 市场估计与预测（2018-2030）
  • 户外栽培
    • 市场估计与预测（2018-2030）

第七章 纽约合法大麻市场細項分析：依最终用途分类（2018-2030）

  • 定义和范围
  • 最终用途细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • 工业用途
    • 市场估计与预测（2018-2030）
  • 医疗用途
    • 市场估计与预测（2018-2030）
    • 慢性疼痛
    • 忧郁症和焦虑
    • 关节炎
    • 创伤后压力症候群（PTSD）
    • 癌症
    • 偏头痛
    • 癫痫
    • 阿兹海默症
    • 多发性硬化症
    • 肌萎缩侧索硬化症
    • 妥瑞症
    • 糖尿病
    • 帕金森氏症
    • 青光眼
    • 其他的
  • 休閒用途
    • 市场估计与预测（2018-2030）

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司市场分析
  • 公司简介
    • Curaleaf Holdings, Inc.
    • New York Hemp Oil
    • COOKIES CREATIVE PRODUCTIONS &CONSULTING, INC.
    • ACREAGE HOLDINGS.
    • Cannabist Company Holdings Inc.
    • Cresco Labs
    • PharmaCann Inc.
    • Canna West Seattle
    • Vireo Health International, Inc.
    • Green Thumb Industries（GTI）
Product Code: GVR-3-68038-420-8

New York Legal Cannabis Market Growth & Trends:

The New York legal cannabis market size is expected to reach USD 3.22 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the legalization of medicinal cannabis, rising consumer disposable income, increasing consumer awareness of the health benefits of cannabis, growing demand for cannabis from the pharmaceutical industry, and the approval of the U.S. Farm Bill are expected to boost market growth.

Cannabis is utilized for managing a range of ailments, including mental health issues, cancer, nausea, and pain, and for adult use purposes. The increasing prevalence of cancer is expected to significantly contribute to the increasing acceptance of medical marijuana over the forecast period. For instance, according to data published by the Government of New York, annually 116,000 New Yorkers are diagnosed with cancer.

The growing awareness among people regarding the therapeutic benefits of cannabis and the rise in cannabis certification educational and training programs fuel market growth. For instance, the travelling training program is a part of the New York State Cannabis Workforce Initiative. It's a collaboration between Cornell University's School of Industrial & Labor Relations and the non-profit Workforce Development Institute, which is partly funded by the state. This program has successfully educated hundreds of individuals in the fundamental aspects of the cannabis industry.

Moreover, the increase in research activities related to cannabis is driving the market growth. In August 2023, regulations for Cannabis Research Licenses were implemented. These regulations allow licensed researchers to cultivate, process, purchase, and possess cannabis for the purpose of testing its composition levels and chemical potency, studying the safety and effectiveness of cannabis as a medical treatment, conducting agricultural or genomic research, as well as carrying out clinical studies of cannabis-derived drug products.

New York Legal Cannabis Market Report Highlights:

  • Based on source, the marijuana segment accounted for the largest revenue share in 2023, owing to the growing research studies on cannabis for its medical use
  • Based on derivatives, the CBD segment dominated the market with the largest revenue share in 2023, owing to the growing adoption of CBD-infused medication, food, and cosmetics
  • Based on cultivation, the indoor cultivation segment accounted for the largest revenue share in 2023, owing to favorable government regulations and a rise in the number of cannabis cultivators
  • Based on end-use, the recreational use segment held the largest market share in 2023 due to the rise in the number of consumers adopting cannabis consumption in the form of smoking and vaping

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Derivatives
    • 1.2.3. Cultivation
    • 1.2.4. End-use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Source outlook
    • 2.2.2. Derivatives outlook
    • 2.2.3. Cultivation outlook
    • 2.2.4. End Use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. New York Legal Cannabis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Case Study Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Landscape

Chapter 4. New York Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Source Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4. Hemp
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Hemp Oil
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Industrial Hemp
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Marijuana
    • 4.5.1. Market estimates and forecasts, 2018 to 2030, (USD Million)
    • 4.5.2. Flower
      • 4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Oil and Tinctures
      • 4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. New York Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Derivatives Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. CBD
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. THC
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. New York Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Cultivation Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Indoor Cultivation
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Greenhouse Cultivation
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Outdoor Cultivation
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. New York Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4. Industrial Use
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Medical Use
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. Chronic Pain
      • 7.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Depression and Anxiety
      • 7.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Arthritis
      • 7.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Post Traumatic Stress Disorder (PTSD)
      • 7.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Cancer
      • 7.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Migraines
      • 7.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Epilepsy
      • 7.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Alzheimer's
      • 7.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.10. Multiple Sclerosis
      • 7.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.11. Amyotrophic Lateral Sclerosis
      • 7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.12. Tourette's
      • 7.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.13. Diabetes
      • 7.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.14. Parkinson's
      • 7.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.15. Glaucoma
      • 7.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.16. Others
      • 7.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Recreational Use
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Position Analysis
  • 8.4. Company Profiles
    • 8.4.1. Curaleaf Holdings, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Service Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. New York Hemp Oil
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Service Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Service Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. ACREAGE HOLDINGS.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Service Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Cannabist Company Holdings Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Service Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Cresco Labs
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Service Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. PharmaCann Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Service Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Canna West Seattle
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Service Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Vireo Health International, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Service Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Green Thumb Industries (GTI)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Service Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 New York legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 4 New York legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 5 New York legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
  • Table 6 New York legal cannabis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market research approaches
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. cannabis market: market outlook
  • Fig. 9 U.S. cannabis competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Industry value chain analysis
  • Fig. 13 New York legal cannabis market driver impact
  • Fig. 14 New York legal cannabis market restraint impact
  • Fig. 15 New York legal cannabis market strategic initiatives analysis
  • Fig. 16 New York legal cannabis market: Source movement analysis
  • Fig. 17 New York legal cannabis market: Source outlook and key takeaways
  • Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
  • Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
  • Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
  • Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flower market estimates and forecasts, 2018 - 2030
  • Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
  • Fig. 24 New York legal cannabis market: Derivatives movement analysis
  • Fig. 25 New York legal cannabis market: Derivatives outlook and key takeaways
  • Fig. 26 CBD market estimates and forecasts, 2018 - 2030
  • Fig. 27 THC market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 New York legal cannabis market: Cultivation movement analysis
  • Fig. 30 New York legal cannabis market: Cultivation outlook and key takeaways
  • Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 34 New York legal cannabis market: End Use movement analysis
  • Fig. 35 New York legal cannabis market: End Use outlook and key takeaways
  • Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
  • Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
  • Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
  • Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
  • Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
  • Fig. 41 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
  • Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
  • Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Alzheimer's market estimates and forecasts, 2018 - 2030
  • Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
  • Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 49 Tourette's market estimates and forecasts, 2018 - 2030
  • Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
  • Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030
  • Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
  • Fig. 55 Key company categorization